News Briefs Archive

New AI Device to Detect Diabetic Eye Disease

April 25, 2018

The Food and Drug Administration has approved an artificial intelligence device to detect diabetic eye disease, according to reporting in the medical journal Formulary.

IDx-DR (IDx LLC), a software program that uses an artificial intelligence AI) algorithm to analyze images of the eye taken with a retinal camera, is the first device authorized for marketing that provides a screening decision without the need for a clinician to also interpret the image or results, the FDA said in a statement. That capability, Formulary notes, makes it usable by healthcare providers who may not normally be involved in eyecare.

The way it works is a doctor uploads the digital images of the patient’s retinas to a cloud server on which IDx-DR software is installed. If the images are of sufficient quality, the software provides the doctor with one of two results: (1) “more than mild diabetic retinopathy detected: refer to an eye care professional” or (2) “negative for more than mild diabetic retinopathy; rescreen in 12 months.”

If a positive result is detected, patients should see an eyecare provider for further diagnostic evaluation and possible treatment as soon as possible.

 

To Top
  
Subscribe Today Free...
And join more than 25,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.
YOUR EMAIL
FIRST NAME
LAST NAME
  
Subscribe Today Free...
And join more than 25,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.
YOUR EMAIL
FIRST NAME
LAST NAME
Subscribe Today for Free...
And join more than 25,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.
Subscribe Today for Free...
And join more than 25,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.